Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A Descriptive Analysis of the Asthma Patient Population in the Emirate of Dubai With Respect to Healthcare Resource Utilization, Costs, and Asthma-related Treatment Pattern

Completed

• Conditions: Asthma

• Registration Number: NCT03963141
• Lead Sponsor: AstraZeneca

Brief Summary

This Retrospective cohort study with an overall objective of to perform a descriptive analysis of the asthma patient population in the Emirate of Dubai with respect to healthcare resource utilization, costs, and asthma-related treatment patterns and outcome.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-04-03
• Study First Submitted QC: 2019-05-23
• Study First Posted: 2019-05-24
• Study Start: 2019-08-31
• Primary Completion: 2022-10-31
• Study Completion: 2022-10-31
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-20
• Last Update Posted: 2024-05-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40541

Inclusion Criteria

• Minimum two claims with asthma diagnosis, 30 days apart, during the identification period
• Minimum 12 months of baseline period
• Age ≥ 18 years on the index date
• Continuous enrolment during the baseline period and at least 180 days of follow-up period; enrolment will be defined based on at least one activity during each 90-day period from the index date

Exclusion Criteria

• Diagnosis of COPD during the baseline period. Diagnosis of COPD will be defined as ≥1 medical claim with an ICD-10 diagnosis in any position

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Asthma-related Cost	1 Year	Total asthma-related cost reported in the databse during December 2015 through November 2018(summarized annually).It will will be computed in the follow-up period and will be reported as a percentage and number of visits per person per year (PPPY). Utilization will be considered "asthma-related" if the associated medical claim(s) has ICD-10 diagnosis code for asthma as the principal diagnosis
Asthma Patients Number	1 Year	Number of unique asthma patients in the database during December 2015 through November 2018(summarized annually).it will be computed in the follow-up period and will be reported as a percentage and number of visits per person per year (PPPY). Utilization will be considered "all-cause" if the associated medical claim(s) has a diagnosis code in any position for any condition.

Secondary Outcome Measures

Name	Time	Method
Asthma-related hopitalizations cost	1 Year	Number of asthma related hopistalizations and cost reported in the database during December 2015 through Novemebr 2018(Summairzed annually)
Astma-related prescription pattern	1 Year	Prescription pattern of asthma-related medication by drug class during December 2015 through November 2018
Severity of Asthma per total number of patients	1 Year	Number of patients classified as Mild, moderate and severe asthmatic patinets as per the international guidlines.

Trial Locations

Locations (1)

Dha Claim; 🇦🇪 Dubai, United Arab Emirates